Article info

Download PDFPDF
A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation
  1. Correspondence to:
    Dr J Tack
    Department of Internal Medicine, Division of Gastroenterology, University Hospital Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium; Jan.Tackmed.kuleuven.ac.be
View Full Text

Citation

Tack J, Müller-Lissner S, Bytzer P, et al
A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation

Publication history

  • Accepted June 24, 2005
  • First published July 14, 2005.
Online issue publication 
October 26, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.